Chlorine in PDB 3ebz: High Resolution Hiv-2 Protease Structure in Complex with Clinical Drug Darunavir
Enzymatic activity of High Resolution Hiv-2 Protease Structure in Complex with Clinical Drug Darunavir
All present enzymatic activity of High Resolution Hiv-2 Protease Structure in Complex with Clinical Drug Darunavir:
3.4.23.47;
Protein crystallography data
The structure of High Resolution Hiv-2 Protease Structure in Complex with Clinical Drug Darunavir, PDB code: 3ebz
was solved by
A.Y.Kovalevsky,
I.T.Weber,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
10.00 /
1.20
|
Space group
|
C 1 2 1
|
Cell size a, b, c (Å), α, β, γ (°)
|
105.408,
30.827,
55.768,
90.00,
91.41,
90.00
|
R / Rfree (%)
|
13.6 /
18.1
|
Other elements in 3ebz:
The structure of High Resolution Hiv-2 Protease Structure in Complex with Clinical Drug Darunavir also contains other interesting chemical elements:
Chlorine Binding Sites:
The binding sites of Chlorine atom in the High Resolution Hiv-2 Protease Structure in Complex with Clinical Drug Darunavir
(pdb code 3ebz). This binding sites where shown within
5.0 Angstroms radius around Chlorine atom.
In total 8 binding sites of Chlorine where determined in the
High Resolution Hiv-2 Protease Structure in Complex with Clinical Drug Darunavir, PDB code: 3ebz:
Jump to Chlorine binding site number:
1;
2;
3;
4;
5;
6;
7;
8;
Chlorine binding site 1 out
of 8 in 3ebz
Go back to
Chlorine Binding Sites List in 3ebz
Chlorine binding site 1 out
of 8 in the High Resolution Hiv-2 Protease Structure in Complex with Clinical Drug Darunavir
Mono view
Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 1 of High Resolution Hiv-2 Protease Structure in Complex with Clinical Drug Darunavir within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Cl503
b:18.8
occ:0.50
|
O
|
A:HOH1010
|
1.0
|
17.3
|
0.5
|
O
|
A:HOH1011
|
1.8
|
17.1
|
0.5
|
ZN
|
A:ZN403
|
2.1
|
19.9
|
0.5
|
O
|
A:LEU99
|
2.9
|
38.7
|
1.0
|
OXT
|
A:LEU99
|
3.3
|
34.6
|
1.0
|
C
|
A:LEU99
|
3.4
|
28.4
|
1.0
|
N3
|
A:IMD304
|
3.5
|
17.4
|
0.5
|
O
|
A:HOH1009
|
3.7
|
15.5
|
0.5
|
C4
|
A:IMD304
|
4.1
|
19.4
|
0.5
|
C2
|
A:IMD304
|
4.6
|
21.2
|
0.5
|
CA
|
A:LEU99
|
4.7
|
25.5
|
1.0
|
N
|
A:LEU99
|
4.9
|
23.2
|
1.0
|
N
|
B:PRO101
|
4.9
|
28.8
|
1.0
|
|
Chlorine binding site 2 out
of 8 in 3ebz
Go back to
Chlorine Binding Sites List in 3ebz
Chlorine binding site 2 out
of 8 in the High Resolution Hiv-2 Protease Structure in Complex with Clinical Drug Darunavir
Mono view
Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 2 of High Resolution Hiv-2 Protease Structure in Complex with Clinical Drug Darunavir within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Cl501
b:15.0
occ:1.00
|
O
|
B:HOH1050
|
2.9
|
24.1
|
1.0
|
N
|
B:ILE146
|
3.3
|
9.2
|
1.0
|
N1
|
B:IMD303
|
3.3
|
11.8
|
0.6
|
CD
|
B:LYS145
|
3.7
|
13.6
|
1.0
|
CA
|
B:LYS145
|
3.8
|
9.9
|
1.0
|
O
|
B:ILE146
|
4.0
|
12.6
|
1.0
|
CB
|
B:LYS145
|
4.0
|
11.0
|
1.0
|
C
|
B:LYS145
|
4.0
|
10.2
|
1.0
|
C2
|
B:IMD303
|
4.1
|
10.3
|
0.6
|
CA
|
B:ILE146
|
4.2
|
9.8
|
1.0
|
CB
|
B:ILE146
|
4.3
|
11.0
|
1.0
|
C5
|
B:IMD303
|
4.3
|
12.9
|
0.6
|
CG
|
B:LYS145
|
4.4
|
10.9
|
1.0
|
C
|
B:ILE146
|
4.6
|
10.6
|
1.0
|
CG1
|
B:ILE146
|
4.7
|
10.0
|
1.0
|
CE
|
B:LYS145
|
4.9
|
19.1
|
1.0
|
O
|
B:PRO144
|
5.0
|
10.8
|
1.0
|
|
Chlorine binding site 3 out
of 8 in 3ebz
Go back to
Chlorine Binding Sites List in 3ebz
Chlorine binding site 3 out
of 8 in the High Resolution Hiv-2 Protease Structure in Complex with Clinical Drug Darunavir
Mono view
Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 3 of High Resolution Hiv-2 Protease Structure in Complex with Clinical Drug Darunavir within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Cl502
b:12.1
occ:0.60
|
ZN
|
B:ZN402
|
2.4
|
13.9
|
0.6
|
O
|
A:HOH1184
|
3.3
|
38.2
|
0.5
|
O
|
B:HOH1002
|
3.4
|
13.6
|
0.6
|
N3
|
B:IMD303
|
3.5
|
11.0
|
0.6
|
N
|
B:GLY148
|
3.5
|
13.7
|
1.0
|
OD2
|
B:ASP130
|
3.7
|
22.4
|
1.0
|
C2
|
B:IMD303
|
3.7
|
10.3
|
0.6
|
C27
|
B:017201
|
3.8
|
11.7
|
1.0
|
CA
|
B:VAL147
|
3.8
|
11.8
|
1.0
|
C31
|
B:017201
|
3.8
|
11.9
|
1.0
|
CG1
|
B:VAL147
|
3.9
|
14.6
|
1.0
|
ZN
|
B:ZN409
|
4.0
|
25.1
|
0.4
|
C
|
B:VAL147
|
4.2
|
11.5
|
1.0
|
O
|
B:GLY148
|
4.2
|
23.9
|
1.0
|
CB
|
B:VAL147
|
4.3
|
10.9
|
1.0
|
O
|
B:ILE146
|
4.3
|
12.6
|
1.0
|
C30
|
B:017201
|
4.3
|
14.3
|
1.0
|
O28
|
B:017201
|
4.4
|
13.1
|
1.0
|
CG2
|
B:VAL147
|
4.5
|
13.0
|
1.0
|
CA
|
B:GLY148
|
4.6
|
15.9
|
1.0
|
C4
|
B:IMD303
|
4.8
|
13.1
|
0.6
|
O26
|
B:017201
|
4.9
|
10.7
|
1.0
|
N
|
B:VAL147
|
4.9
|
10.5
|
1.0
|
C
|
B:GLY148
|
4.9
|
14.4
|
1.0
|
C29
|
B:017201
|
4.9
|
14.2
|
1.0
|
CG
|
B:ASP130
|
5.0
|
14.8
|
1.0
|
|
Chlorine binding site 4 out
of 8 in 3ebz
Go back to
Chlorine Binding Sites List in 3ebz
Chlorine binding site 4 out
of 8 in the High Resolution Hiv-2 Protease Structure in Complex with Clinical Drug Darunavir
Mono view
Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 4 of High Resolution Hiv-2 Protease Structure in Complex with Clinical Drug Darunavir within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Cl504
b:23.5
occ:0.50
|
ZN
|
B:ZN407
|
2.2
|
28.7
|
0.5
|
O
|
B:HOH1005
|
3.1
|
26.5
|
0.5
|
O
|
B:HOH1008
|
3.5
|
43.2
|
0.5
|
O
|
B:HOH1003
|
3.6
|
21.8
|
0.5
|
CA
|
B:GLY117
|
3.7
|
12.9
|
1.0
|
OE1
|
B:GLU165
|
3.7
|
58.3
|
1.0
|
OE2
|
B:GLU165
|
4.0
|
45.3
|
1.0
|
CD
|
B:GLU165
|
4.1
|
34.8
|
1.0
|
CG
|
B:TYR114
|
4.1
|
12.2
|
1.0
|
O
|
B:HOH1028
|
4.3
|
12.8
|
1.0
|
CD1
|
B:TYR114
|
4.3
|
15.4
|
1.0
|
CB
|
B:TYR114
|
4.3
|
10.6
|
1.0
|
N
|
B:GLY117
|
4.4
|
12.2
|
1.0
|
CD2
|
B:TYR114
|
4.4
|
22.3
|
1.0
|
C
|
B:GLY117
|
4.6
|
11.3
|
1.0
|
O
|
B:GLY117
|
4.6
|
13.9
|
1.0
|
CE1
|
B:TYR114
|
4.8
|
17.5
|
1.0
|
CE2
|
B:TYR114
|
4.9
|
24.8
|
1.0
|
|
Chlorine binding site 5 out
of 8 in 3ebz
Go back to
Chlorine Binding Sites List in 3ebz
Chlorine binding site 5 out
of 8 in the High Resolution Hiv-2 Protease Structure in Complex with Clinical Drug Darunavir
Mono view
Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 5 of High Resolution Hiv-2 Protease Structure in Complex with Clinical Drug Darunavir within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Cl505
b:17.0
occ:0.50
|
ZN
|
B:ZN404
|
2.3
|
18.9
|
0.5
|
O
|
B:HOH1103
|
3.2
|
39.1
|
1.0
|
N
|
B:TRP106
|
3.3
|
16.2
|
1.0
|
CB
|
B:SER104
|
3.5
|
26.1
|
1.0
|
N3
|
B:IMD305
|
3.5
|
15.3
|
0.5
|
N
|
B:LEU105
|
3.6
|
14.0
|
1.0
|
N
|
B:LYS107
|
3.6
|
14.9
|
1.0
|
CB
|
B:TRP106
|
3.7
|
21.3
|
1.0
|
O
|
B:HOH1006
|
3.7
|
14.8
|
0.5
|
CL
|
B:CL506
|
3.7
|
27.4
|
0.5
|
O
|
B:HOH1004
|
3.7
|
15.8
|
0.5
|
CG
|
B:LYS107
|
3.8
|
21.7
|
1.0
|
C
|
B:SER104
|
3.8
|
15.8
|
1.0
|
CA
|
B:TRP106
|
3.9
|
16.1
|
1.0
|
CA
|
B:SER104
|
3.9
|
17.8
|
1.0
|
N
|
B:SER104
|
3.9
|
15.6
|
1.0
|
O
|
B:HOH1075
|
3.9
|
16.7
|
1.0
|
CD1
|
B:TRP106
|
4.1
|
25.0
|
1.0
|
C4
|
B:IMD305
|
4.1
|
13.8
|
0.5
|
C
|
B:TRP106
|
4.2
|
16.1
|
1.0
|
C
|
B:LEU105
|
4.3
|
13.4
|
1.0
|
CG
|
B:TRP106
|
4.3
|
21.1
|
1.0
|
CA
|
B:LEU105
|
4.4
|
13.4
|
1.0
|
C2
|
B:IMD305
|
4.5
|
15.3
|
0.5
|
O
|
B:SER104
|
4.5
|
18.1
|
1.0
|
CB
|
B:LYS107
|
4.5
|
19.8
|
1.0
|
CE
|
B:LYS107
|
4.5
|
29.7
|
1.0
|
CD
|
B:LYS107
|
4.5
|
20.8
|
1.0
|
CA
|
B:LYS107
|
4.6
|
15.6
|
1.0
|
OG
|
B:SER104
|
4.7
|
34.2
|
1.0
|
O
|
B:LYS107
|
4.7
|
13.9
|
1.0
|
|
Chlorine binding site 6 out
of 8 in 3ebz
Go back to
Chlorine Binding Sites List in 3ebz
Chlorine binding site 6 out
of 8 in the High Resolution Hiv-2 Protease Structure in Complex with Clinical Drug Darunavir
Mono view
Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 6 of High Resolution Hiv-2 Protease Structure in Complex with Clinical Drug Darunavir within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Cl506
b:27.4
occ:0.50
|
ZN
|
B:ZN404
|
2.2
|
18.9
|
0.5
|
O
|
B:HOH1006
|
2.3
|
14.8
|
0.5
|
O
|
B:HOH1112
|
2.6
|
39.8
|
1.0
|
N3
|
B:IMD305
|
3.5
|
15.3
|
0.5
|
C2
|
B:IMD305
|
3.6
|
15.3
|
0.5
|
O
|
B:HOH1004
|
3.6
|
15.8
|
0.5
|
CL
|
B:CL505
|
3.7
|
17.0
|
0.5
|
CB
|
B:TRP106
|
3.9
|
21.3
|
1.0
|
CB
|
B:LYS107
|
3.9
|
19.8
|
1.0
|
N
|
B:LYS107
|
4.0
|
14.9
|
1.0
|
CG
|
B:LYS107
|
4.0
|
21.7
|
1.0
|
C
|
B:TRP106
|
4.2
|
16.1
|
1.0
|
CD
|
B:LYS107
|
4.3
|
20.8
|
1.0
|
O
|
B:HOH1086
|
4.4
|
30.4
|
1.0
|
CA
|
B:LYS107
|
4.5
|
15.6
|
1.0
|
O
|
B:TRP106
|
4.6
|
20.0
|
1.0
|
CA
|
B:TRP106
|
4.6
|
16.1
|
1.0
|
C4
|
B:IMD305
|
4.8
|
13.8
|
0.5
|
N1
|
B:IMD305
|
4.9
|
15.5
|
0.5
|
|
Chlorine binding site 7 out
of 8 in 3ebz
Go back to
Chlorine Binding Sites List in 3ebz
Chlorine binding site 7 out
of 8 in the High Resolution Hiv-2 Protease Structure in Complex with Clinical Drug Darunavir
Mono view
Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 7 of High Resolution Hiv-2 Protease Structure in Complex with Clinical Drug Darunavir within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Cl507
b:25.4
occ:0.50
|
ZN
|
B:ZN408
|
2.2
|
25.0
|
0.5
|
O
|
B:HOH1133
|
2.8
|
26.4
|
0.5
|
NZ
|
B:LYS145
|
3.2
|
20.7
|
1.0
|
OE1
|
B:GLU158
|
3.5
|
29.6
|
1.0
|
O
|
B:HOH1170
|
3.5
|
20.1
|
0.5
|
O
|
B:HOH1001
|
3.6
|
21.0
|
0.5
|
C5
|
B:IMD303
|
3.6
|
12.9
|
0.6
|
CE
|
B:LYS145
|
3.7
|
19.1
|
1.0
|
O
|
B:HOH1123
|
3.8
|
22.3
|
0.5
|
O
|
B:HOH1050
|
4.0
|
24.1
|
1.0
|
CD
|
B:LYS145
|
4.1
|
13.6
|
1.0
|
CD
|
B:GLU158
|
4.3
|
20.0
|
1.0
|
OE2
|
B:GLU158
|
4.4
|
26.6
|
1.0
|
C4
|
B:IMD303
|
4.4
|
13.1
|
0.6
|
N1
|
B:IMD303
|
4.6
|
11.8
|
0.6
|
CG
|
B:LYS145
|
5.0
|
10.9
|
1.0
|
|
Chlorine binding site 8 out
of 8 in 3ebz
Go back to
Chlorine Binding Sites List in 3ebz
Chlorine binding site 8 out
of 8 in the High Resolution Hiv-2 Protease Structure in Complex with Clinical Drug Darunavir
Mono view
Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 8 of High Resolution Hiv-2 Protease Structure in Complex with Clinical Drug Darunavir within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Cl508
b:26.7
occ:0.40
|
ZN
|
B:ZN409
|
2.3
|
25.1
|
0.4
|
O
|
B:HOH1002
|
2.9
|
13.6
|
0.6
|
OD1
|
B:ASP130
|
3.2
|
22.5
|
1.0
|
CB
|
B:ASP129
|
3.8
|
13.5
|
1.0
|
C4
|
B:IMD303
|
3.8
|
13.1
|
0.6
|
CG
|
B:ASP130
|
4.0
|
14.8
|
1.0
|
ZN
|
B:ZN402
|
4.0
|
13.9
|
0.6
|
OD2
|
B:ASP130
|
4.0
|
22.4
|
1.0
|
OD2
|
B:ASP129
|
4.2
|
20.4
|
1.0
|
N3
|
B:IMD303
|
4.3
|
11.0
|
0.6
|
CG
|
B:ASP129
|
4.4
|
17.9
|
1.0
|
O
|
B:HOH1088
|
4.4
|
41.8
|
1.0
|
O
|
B:HOH1170
|
4.4
|
20.1
|
0.5
|
O
|
B:HOH1098
|
4.8
|
27.9
|
1.0
|
C
|
B:ASP129
|
4.8
|
10.5
|
1.0
|
O
|
B:ASP129
|
4.8
|
13.5
|
1.0
|
C5
|
B:IMD303
|
4.9
|
12.9
|
0.6
|
CA
|
B:ASP129
|
5.0
|
11.2
|
1.0
|
|
Reference:
A.Y.Kovalevsky,
J.M.Louis,
A.Aniana,
A.K.Ghosh,
I.T.Weber.
Structural Evidence For Effectiveness of Darunavir and Two Related Antiviral Inhibitors Against Hiv-2 Protease J.Mol.Biol. V. 384 178 2008.
ISSN: ISSN 0022-2836
PubMed: 18834890
DOI: 10.1016/J.JMB.2008.09.031
Page generated: Sat Jul 20 18:45:30 2024
|